Table A2.

PFS and OS for Patients Who Met Eligibility Criteria (n = 18)

Statistic	Experimental Group (n = 18)				Historical Cohort (n = 17)
	Postvaccination		Postsurgery		Postsurgery
	No.	95% CI	No.	95% CI	No.	95% CI
PFS, months
Median	10.4	5.4 to 12.9	14.2	9.9 to 17.6	6.3	4.1 to 9.0
6-month, %	0.67	0.40 to 0.83	0.94	0.67 to 0.99	0.59	0.33 to 0.78
12-month, %	0.44	0.22 to 0.65	0.28	0.10 to 0.48	0.24	0.07 to 0.45
24-month, %	0.28	0.10 to 0.49	0.28	0.10 to 0.49	0.06	0.02 to 0.31
OS, months
Median	21.2	17.0 to 44.9	26.0	21.0 to 47.7	15.0	11.4 to 19.7
6-month, %	1.00		1.00		0.94	0.65 to 0.99
12-month, %	0.94	0.67 to 0.99	0.94	0.67 to 0.99	0.71	0.43 to 0.86
24-month, %	0.47	0.23 to 0.68	0.53	0.28 to 0.73	0.06	0.004 to 0.24

Abbreviations: PFS, progression-free survival; OS, overall survival.